Stay updated on T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial
Sign up to get notified when there's something new on the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page.

Latest updates to the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page
- Check2 days agoChange DetectedThe study's history now includes a new revision tag, v3.6.3, replacing the previous v3.6.2. This indicates a minor update to the page's metadata reflected in the version history.SummaryDifference0.1%

- Check10 days agoChange DetectedA new revision entry v3.6.2 was added to the history, replacing v3.6.0. This reflects a minor deployment update to the page without altering study information.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRecruitment status updated to indicate that enrollment has ended. The version history was updated to include Revision: v3.6.0 and remove Revision: v3.5.5.SummaryDifference0.5%

- Check31 days agoChange DetectedA new revision v3.5.5 was added to the version history and the older v3.5.4 entry was removed from the visible history.SummaryDifference0.1%

- Check52 days agoChange DetectedA new revision entry for v3.5.4 was added to the Record History, replacing the previous v3.5.3 in the history log.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page version/revision label was updated from **v3.5.2** to **v3.5.3**, indicating a minor interface or system update without changing the study record content.SummaryDifference0.1%

Stay in the know with updates to T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page.